LumiraDx Investor Presentation Deck

LumiraDx is focused on transforming community-based healthcare by providing fast, accurate, cost effective and comprehensive diagnostic information to healthcare providers enabling better medical decisions leading to improved outcomes Cumulative Instruments Shipped Strip Manufacturing Capacity / Month Countries served Cumulative Revenue +$750m Cumulated Sales Since 2019 2019 -200 4 Million lumiraDx™ 6 $23M 2020 -8,000 16 Million LumiraDx Overview 27 $162M 2021 -21,000 28 Million 98 $583M LumiraDx currently has 12 tests approved on its Platform, with a pipeline of over 50 tests Q2 2022 -25,000 28 Million 105 $754M Copyright © 2022 LumiraDx Ltd. All Rights Reserved. Worldwide 25k+ Platforms Placed Globally Instrument Placement Locations

View entire presentation